Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionMHC class Ib protein binding

KIR2DL1 KIR2DS4 KIR3DL2

1.79e-0516653GO:0023029
GeneOntologyMolecularFunctionMHC class Ib receptor activity

KIR2DL1 KIR2DS4 KIR3DL2

3.07e-0519653GO:0032394
GeneOntologyCellularComponentearly endosome membrane

VPS16 KIR2DL1 KIR2DS4 KIR3DL2 SNX13

5.16e-04212655GO:0031901
GeneOntologyCellularComponentendosome membrane

ABCA3 GRB14 VPS16 KIR2DL1 KIR2DS4 KIR3DL2 NOTCH1 SNX13

5.37e-04602658GO:0010008
GeneOntologyCellularComponentcytoplasmic vesicle membrane

ABCA3 ABCA13 SYT6 GRB14 VPS16 KIR2DL1 KIR2DS4 KIR3DL2 NOTCH1 SNTB2 C2CD5 SNX13

6.23e-0413076512GO:0030659
GeneOntologyCellularComponentvesicle membrane

ABCA3 ABCA13 SYT6 GRB14 VPS16 KIR2DL1 KIR2DS4 KIR3DL2 NOTCH1 SNTB2 C2CD5 SNX13

7.03e-0413256512GO:0012506
GeneOntologyCellularComponentearly endosome

LIPC MYO1D VPS16 KIR2DL1 KIR2DS4 KIR3DL2 SNX13

7.19e-04481657GO:0005769
GeneOntologyCellularComponentendosome

ABCA3 LIPC MYO1D GRB14 VPS16 KIR2DL1 KIR2DS4 KIR3DL2 BIRC6 NOTCH1 SNX13

8.70e-0411676511GO:0005768
GeneOntologyCellularComponentFAR/SIN/STRIPAK complex

PPP2CA PPP2CB

1.26e-0317652GO:0090443
GeneOntologyCellularComponentprotein phosphatase type 2A complex

PPP2CA PPP2CB

1.41e-0318652GO:0000159
HumanPhenoSpinal instability

EXTL3 NOTCH2

3.95e-053192HP:0005881
HumanPhenoCervical instability

EXTL3 NOTCH2

3.95e-053192HP:0008462
DomainDUF3454

NOTCH1 NOTCH2

3.46e-053642PF11936
DomainDUF3454_notch

NOTCH1 NOTCH2

3.46e-053642IPR024600
DomainDUF3454

NOTCH1 NOTCH2

3.46e-053642SM01334
Domainig

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

4.70e-05190646PF00047
DomainImmunoglobulin

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

4.70e-05190646IPR013151
DomainNotch

NOTCH1 NOTCH2

6.90e-054642IPR008297
DomainNODP

NOTCH1 NOTCH2

6.90e-054642PF07684
DomainNotch_NODP_dom

NOTCH1 NOTCH2

6.90e-054642IPR011656
DomainNotch_NOD_dom

NOTCH1 NOTCH2

6.90e-054642IPR010660
DomainNOD

NOTCH1 NOTCH2

6.90e-054642PF06816
DomainNOD

NOTCH1 NOTCH2

6.90e-054642SM01338
DomainNODP

NOTCH1 NOTCH2

6.90e-054642SM01339
DomainLNR

NOTCH1 NOTCH2

1.15e-045642PS50258
DomainNotch_dom

NOTCH1 NOTCH2

2.40e-047642IPR000800
DomainNotch

NOTCH1 NOTCH2

2.40e-047642PF00066
DomainNL

NOTCH1 NOTCH2

2.40e-047642SM00004
DomainABC_tran

ABCA3 ABCA13 ABCD4

5.95e-0448643PF00005
DomainABC_TRANSPORTER_2

ABCA3 ABCA13 ABCD4

5.95e-0448643PS50893
DomainABC_TRANSPORTER_1

ABCA3 ABCA13 ABCD4

6.32e-0449643PS00211
DomainABC_transporter-like

ABCA3 ABCA13 ABCD4

6.70e-0450643IPR003439
DomainABC_A

ABCA3 ABCA13

7.46e-0412642IPR026082
DomainSer/Thr-sp_prot-phosphatase

PPP2CA PPP2CB

8.80e-0413642IPR006186
DomainSER_THR_PHOSPHATASE

PPP2CA PPP2CB

8.80e-0413642PS00125
DomainPP2Ac

PPP2CA PPP2CB

8.80e-0413642SM00156
DomainSynaptotagmin

SYT6 C2CD5

2.11e-0320642IPR001565
DomainIg-like_fold

PLXNC1 NXPE1 KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

2.74e-03706648IPR013783
DomainIG

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

3.15e-03421646SM00409
DomainIg_sub

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

3.15e-03421646IPR003599
DomainCalcineurin-like_PHP_ApaH

PPP2CA PPP2CB

4.13e-0328642IPR004843
DomainhEGF

NOTCH1 NOTCH2

4.13e-0328642PF12661
DomainMetallophos

PPP2CA PPP2CB

4.13e-0328642PF00149
DomainMetallo-depent_PP-like

PPP2CA PPP2CB

4.73e-0330642IPR029052
Domain-

PPP2CA PPP2CB

4.73e-03306423.60.21.10
DomainUBA

USP13 HUWE1

4.73e-0330642SM00165
Domain-

SEH1L PLXNC1 WDFY3 BIRC6 WDR62

5.64e-033336452.130.10.10
DomainWD40/YVTN_repeat-like_dom

SEH1L PLXNC1 WDFY3 BIRC6 WDR62

5.79e-03335645IPR015943
DomainIG_LIKE

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

6.62e-03491646PS50835
DomainUBA

USP13 HUWE1

6.76e-0336642PF00627
Domain-

PLXNC1 NXPE1 KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL2

7.41e-036636472.60.40.10
DomainIg-like_dom

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

7.42e-03503646IPR007110
PathwayKEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY

PTK2B KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

7.45e-07137537M5669
PathwayKEGG_ANTIGEN_PROCESSING_AND_PRESENTATION

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

9.04e-0788536M16004
PathwayKEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR

VPS16 BIRC6 EPG5

2.71e-0516533M47978
PathwayREACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3

NOTCH1 NOTCH2

1.38e-045532M27411
PathwayREACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM

NOTCH1 NOTCH2

2.06e-046532M27068
PathwayREACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS

PPP2CA PPP2CB

2.88e-047532M26992
PathwayKEGG_ABC_TRANSPORTERS

ABCA3 ABCA13 ABCD4

5.96e-0444533M11911
PathwayREACTOME_MASTL_FACILITATES_MITOTIC_PROGRESSION

PPP2CA PPP2CB

6.12e-0410532M27176
PathwayREACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1

PPP2CA PPP2CB

6.12e-0410532MM14509
PathwayREACTOME_DAP12_INTERACTIONS

KIR2DS1 KIR2DS4 KIR2DS5

6.80e-0446533M27151
PathwayKEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION

NOTCH1 NOTCH2

7.46e-0411532M47865
PathwayBIOCARTA_HES_PATHWAY

NOTCH1 NOTCH2

8.94e-0412532MM1562
PathwayBIOCARTA_HES_PATHWAY

NOTCH1 NOTCH2

8.94e-0412532M22042
PathwayREACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM

PPP2CA PPP2CB

8.94e-0412532M27950
PathwayKEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380

NOTCH1 NOTCH2

8.94e-0412532M47532
PathwayKEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381

NOTCH1 NOTCH2

8.94e-0412532M47533
PathwayREACTOME_ERKS_ARE_INACTIVATED

PPP2CA PPP2CB

1.05e-0313532MM14811
PathwayREACTOME_ERKS_ARE_INACTIVATED

PPP2CA PPP2CB

1.05e-0313532M8410
PathwayKEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY

NOTCH1 NOTCH2

1.05e-0313532M47423
PathwayREACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1

PPP2CA PPP2CB

1.05e-0313532M1015
PathwayWP_DOPAMINE_METABOLISM

PPP2CA PPP2CB

1.05e-0313532M39622
PathwayKEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382

NOTCH1 NOTCH2

1.05e-0313532M47534
PathwayREACTOME_DAP12_INTERACTIONS

KIR2DL1 KIR2DS4 KIR3DL2

1.09e-0354533MM14871
PathwayREACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS

PPP2CA PPP2CB

1.41e-0315532M27407
PathwayKEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_PROPHASE

PPP2CA PPP2CB

1.61e-0316532M47870
PathwayREACTOME_DARPP_32_EVENTS

PPP2CA PPP2CB

1.61e-0316532MM14699
PathwayREACTOME_SPRY_REGULATION_OF_FGF_SIGNALING

PPP2CA PPP2CB

1.61e-0316532MM14541
PathwayREACTOME_SPRY_REGULATION_OF_FGF_SIGNALING

PPP2CA PPP2CB

1.61e-0316532M514
PathwayREACTOME_PLATELET_SENSITIZATION_BY_LDL

PPP2CA PPP2CB

1.82e-0317532MM15096
PathwayREACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE

PPP2CA PPP2CB

1.82e-0317532M27083
PathwayREACTOME_PLATELET_SENSITIZATION_BY_LDL

PPP2CA PPP2CB

1.82e-0317532M919
PathwayREACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI

NOTCH1 NOTCH2

2.04e-0318532M614
PathwayWP_PROTEOGLYCAN_BIOSYNTHESIS

SLC35B2 EXTL3

2.04e-0318532M39865
PathwayREACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE

PPP2CA PPP2CB

2.04e-0318532MM14759
PathwayKEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY

PPP2CA PPP2CB

2.28e-0319532M47525
PathwayREACTOME_ERK_MAPK_TARGETS

PPP2CA PPP2CB

2.28e-0319532MM14780
Pubmed

[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

3.39e-141266620137308
Pubmed

Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

1.10e-131466619875891
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

1.10e-131466615896204
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

1.83e-131566620082646
Pubmed

Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

1.83e-131566619926642
Pubmed

[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

1.83e-131566620356536
Pubmed

Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

1.83e-131566620643584
Pubmed

KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

1.83e-131566617498266
Pubmed

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

1.83e-131566619326408
Pubmed

Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

2.92e-131666619897003
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

2.92e-131666619000141
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

2.92e-131666620670355
Pubmed

Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

2.92e-131666619527230
Pubmed

Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

2.92e-131666620652381
Pubmed

Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

2.92e-131666618668235
Pubmed

Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

2.92e-131666619279038
Pubmed

No association of KIR genes with Behcet's disease.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

2.92e-131666617868255
Pubmed

A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

2.92e-131666618643961
Pubmed

Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

2.92e-131666619309280
Pubmed

Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

2.92e-131666620331834
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

2.92e-131666616403292
Pubmed

HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

2.92e-131666620210919
Pubmed

Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

4.50e-131766619032228
Pubmed

The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

4.50e-131766620173784
Pubmed

The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

4.50e-131766620173792
Pubmed

Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

4.50e-131766620483367
Pubmed

[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

4.50e-131766619968064
Pubmed

[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

4.50e-131766619218127
Pubmed

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

4.50e-131766620878400
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

4.50e-131766620650299
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

4.50e-131766619450876
Pubmed

Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

4.50e-131766619761533
Pubmed

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

6.74e-131866619630074
Pubmed

Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

6.74e-131866620519398
Pubmed

Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

6.74e-131866620200544
Pubmed

Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

6.74e-131866619046302
Pubmed

Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

6.74e-131866619846535
Pubmed

Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

6.74e-131866620580654
Pubmed

KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

9.84e-131966618571006
Pubmed

Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

9.84e-131966618778326
Pubmed

Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

9.84e-131966620600442
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

9.84e-131966618848853
Pubmed

NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

1.18e-12866518681957
Pubmed

Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

1.40e-122066620193031
Pubmed

HLA and KIR frequencies in Sicilian Centenarians.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

1.40e-122066620426625
Pubmed

Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

1.96e-122166619861144
Pubmed

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.

KIR2DL1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

2.64e-1296657749980
Pubmed

Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

2.69e-122266620492596
Pubmed

Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS5 KIR3DL2

5.27e-121066512559621
Pubmed

[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

9.65e-121166519664392
Pubmed

Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

1.65e-111266520371502
Pubmed

Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

1.65e-111266519181658
Pubmed

Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

1.65e-111266519936734
Pubmed

Immunogenetic characteristics of patients with autoimmune gastritis.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

1.70e-112966620082482
Pubmed

[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

2.68e-111366518687225
Pubmed

KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

2.68e-111366519934297
Pubmed

Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

2.68e-111366519120281
Pubmed

Multiple sclerosis associates with LILRA3 deletion in Spanish patients.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

4.17e-111466519421224
Pubmed

[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL2

4.17e-111466519489269
Pubmed

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

KIR2DL1 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL2

4.17e-111466518945962
Pubmed

Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

5.75e-113566619683555
Pubmed

In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans.

KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

5.90e-11566419410616
Pubmed

Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

6.24e-111566519850842
Pubmed

Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

6.24e-111566520207982
Pubmed

Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

6.24e-111566519493232
Pubmed

KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

1.28e-101766519169284
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.

KIR2DL1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

1.77e-101866520210918
Pubmed

Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.

KIR2DL1 KIR2DS4 KIR2DS5 KIR3DL2

4.12e-10766414607943
Pubmed

Human diversity in killer cell inhibitory receptor genes.

KIR2DL1 KIR2DS1 KIR2DS3 KIR3DL2

8.23e-1086649430221
Pubmed

Alternatively spliced forms of human killer inhibitory receptors.

KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

1.48e-0996648662091
Pubmed

Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4

1.48e-09966418340360
Pubmed

Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.

KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

2.46e-091066421206914
Pubmed

Natural killer cells and immune surveillance.

KIR2DL1 KIR2DS3 KIR2DS4 KIR2DS5

3.86e-091166418830515
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].

KIR2DL1 KIR2DS4 KIR2DS5 KIR3DL2

5.79e-091266417490516
Pubmed

A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation.

KIR2DS3 KIR2DS4 KIR2DS5

6.53e-0936638765026
Pubmed

Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.

KIR2DS1 KIR2DS3 KIR2DS5

6.53e-09366319500138
Pubmed

A role for KIR gene variants other than KIR2DS1 in conferring susceptibility to psoriasis.

KIR2DS1 KIR2DS3 KIR2DS5

2.61e-08466316829306
Pubmed

Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function.

KIR2DL1 KIR2DS1 KIR2DS5

6.51e-08566318624290
Pubmed

Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual.

KIR2DL1 KIR2DS1 KIR2DS4

6.51e-08566310424431
Pubmed

KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C.

KIR2DL1 KIR2DS4 KIR3DL2

1.30e-07666319858347
Pubmed

Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X.

KIR2DL1 KIR2DS4 KIR3DL2

2.27e-07766312618911
Pubmed

Expression of a killer cell receptor-like gene in plastic regions of the central nervous system.

KIR2DL1 KIR2DS4 KIR3DL2

2.27e-07766315748957
Pubmed

Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis.

KIR2DL1 KIR2DS4 KIR3DL2

2.27e-07766326928464
Pubmed

Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.

KIR2DL1 KIR2DS1 KIR2DS4

2.27e-07766311169255
Pubmed

Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.

KIR2DL1 KIR2DS1 KIR2DS3

2.27e-0776639430220
Pubmed

A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.

KIR2DL1 KIR2DS4 KIR3DL2

3.63e-07866315730517
Pubmed

Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population.

KIR2DS1 KIR2DS3 KIR3DL2

5.44e-07966318074414
Pubmed

Distribution of KIR genes in the Czech population.

KIR2DL1 KIR2DS4 KIR3DL2

5.44e-07966318186800
Pubmed

A role for notch signaling in human corneal epithelial cell differentiation and proliferation.

NOTCH1 NOTCH2

3.55e-06266217652726
Pubmed

Notch1 and Notch2 expression in osteoblast precursors regulates femoral microarchitecture.

NOTCH1 NOTCH2

3.55e-06266224508387
Pubmed

Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A.

PPP2CA PPP2CB

3.55e-0626622555176
Pubmed

Clinical role of Notch signaling pathway in intraductal papillary mucinous neoplasm of the pancreas.

NOTCH1 NOTCH2

3.55e-06266225041344
Pubmed

Extracellular domain alterations impact surface expression of stimulatory natural killer cell receptor KIR2DS5.

KIR2DS1 KIR2DS5

3.55e-06266218682925
Pubmed

Notch controls generation and function of human effector CD8+ T cells.

NOTCH1 NOTCH2

3.55e-06266223380742
Pubmed

The RabGAPs EPI64A and EPI64B regulate the apical structure of epithelial cells †.

TBC1D10B TBC1D10A

3.55e-06266234757852
Pubmed

Association between KIR gene polymorphisms and type 1 diabetes mellitus (T1DM) susceptibility: A PRISMA-compliant meta-analysis.

KIR2DL1 KIR2DS1

3.55e-06266229384924
Pubmed

Endothelium and NOTCH specify and amplify aorta-gonad-mesonephros-derived hematopoietic stem cells.

NOTCH1 NOTCH2

3.55e-06266225866967
Pubmed

Xylosyl Extension of O-Glucose Glycans on the Extracellular Domain of NOTCH1 and NOTCH2 Regulates Notch Cell Surface Trafficking.

NOTCH1 NOTCH2

3.55e-06266232423029
Pubmed

Differential Notch1 and Notch2 expression and frequent activation of Notch signaling in gastric cancers.

NOTCH1 NOTCH2

3.55e-06266221466361
Pubmed

Notch signaling regulates formation of the three-dimensional architecture of intrahepatic bile ducts in mice.

NOTCH1 NOTCH2

3.55e-06266220069650
Cytoband19q13.4

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

1.79e-097966619q13.4
Cytoband7p21.1

MACC1 SNX13

4.62e-04226627p21.1
Cytoband11q13.2

CPT1A CARNS1

2.11e-034766211q13.2
GeneFamilyCD molecules|Killer cell immunoglobulin like receptors

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

3.51e-1218466620
GeneFamilyADAM metallopeptidase domain containing|CD molecules

PLXNC1 KIR2DL1 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL2

4.62e-04394466471
GeneFamilyProtein phosphatase catalytic subunits|EF-hand domain containing

PPP2CA PPP2CB

4.85e-0413462693
GeneFamilyATP binding cassette subfamily A

ABCA3 ABCA13

5.65e-0414462805
GeneFamilyProtein phosphatase catalytic subunits|STRIPAK complex

PPP2CA PPP2CB

1.17e-03204621371
CoexpressionKAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS5

6.31e-0649644M40909
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

ABCA3 AADACL3 CYP4F22 KIR2DL1 KIR3DL2

4.92e-061756358fb8c4b9e2d9b7d737f59cd9bd3dc2bca5a8dfc4
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PTK2B MYO1D DGKG CDH9 SNTB2

5.06e-061766350710689e66deba179b0a8038cdd56b4834984f12
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GDA MYO1D DGKG CDH9 SNTB2

5.50e-061796351ac79c82c52fa95bb4e170ab20fec0f648db2134
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

MACC1 ABCA3 MYO1D ABCA13 MICAL2

5.80e-06181635576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCellCOVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type

FREM2 GDA SYT6 CDH9 SORCS1

5.80e-061816356980ea624151da32b7f537f263e40fcb87a02e81
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PTK2B MYO1D CDH9 SNTB2 SORCS1

5.96e-0618263531efc06d6b073e8e341648207093e5f33c6f9183
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

FREM2 USP13 MACC1 ABCA3 GRB14

7.53e-06191635ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCellNeuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R--|Neuronal / cells hierarchy compared to all cells using T-Statistic

MYO1D DGKG CDH9 SNTB2 SORCS1

9.41e-06200635dc8702e3cb4ac8c1a9849fc8abf8777f12d55b0b
ToppCellNeuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R---L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic

MYO1D DGKG CDH9 SNTB2 SORCS1

9.41e-06200635d92d51021ab6d78e9c8f89f7c150181004dcbcbd
ToppCellNeuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R-|Neuronal / cells hierarchy compared to all cells using T-Statistic

MYO1D DGKG CDH9 SNTB2 SORCS1

9.41e-06200635cbbb9044283ff9ab63bbfc24d7a9f006b1372705
ToppCellNeuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R|Neuronal / cells hierarchy compared to all cells using T-Statistic

MYO1D DGKG CDH9 SNTB2 SORCS1

9.41e-06200635a3e36bbeed19431d07bc205f14f4e0f12bd8f730
ToppCelldroplet-Fat-SCAT-30m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MACC1 GLP1R TRIM10 SORCS1

7.79e-0516063467ee7a314d7d4d3ea206e0158083f36f6dd7e80b
ToppCelldroplet-Fat-SCAT-30m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MACC1 GLP1R TRIM10 SORCS1

7.79e-05160634fc76337ad766c859db390ef8b6fb9caeaace3a56
ToppCelldroplet-Fat-SCAT-30m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MACC1 GLP1R TRIM10 SORCS1

7.79e-05160634759749f708c3a2b36692d42499f19aff937e592f
ToppCellSevere-Lymphoid-NK-|Severe / Condition, Lineage, Cell class and cell subclass

ZNF136 ABCD4 KIR2DL1 KIR3DL2

7.79e-05160634d276c6cb8317d5fb19e7b4fe5238abaf0272d4c6
ToppCellControl-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

GDA PLXNC1 DGKG NOTCH2

8.18e-05162634aa80452b972bb8ad3670ffaba4ce26fadb33b185
ToppCellfacs-Liver-Non-hepatocytes-24m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GDA ABCA13 CARNS1 NOTCH2

8.37e-05163634abec4389cd88252449f110fe95416d67424b403a
ToppCelldroplet-Marrow-BM_(NON-STC)-30m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GDA ABCA13 SMYD3 TRIM10

9.20e-051676341bd27ffe381d26731b6d4cc5f29b27f1bac4473b
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

GDA SYT6 CDH9 SORCS1

9.41e-05168634fa0d251693935116adf633d02b7ec4a295100865
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

GDA SYT6 CDH9 SORCS1

1.01e-04171634f5014e3c387fe3118944af392abe10d6b9b0abab
ToppCelldroplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RLF GDA ABCA13 PLXNC1

1.03e-04172634d354424c1f861b6607dfd63b9724f4c237b30275
ToppCellfacs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PTK2B GDA GON4L DGKG

1.05e-04173634c31076c725f4cd912c56903592a2d9356ae59f54
ToppCellfacs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PTK2B GDA GON4L DGKG

1.05e-04173634a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PTK2B GDA GRB14 CDH9

1.13e-04176634212e643c50c68462d4b016428ab30eeb7868ef40
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-2|TCGA-Colorectal / Sample_Type by Project: Shred V9

ABCA3 KIR2DL1 KIR2DS4 KIR3DL2

1.13e-041766341870860a9ebe7a655c4ea8898427e1097ee23113
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

MYO1D DGKG CDH9 SNTB2

1.15e-04177634921783ed0fe20294d2f384d9136924b679df01bb
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

MYO1D DGKG CDH9 SNTB2

1.18e-041786346f61490d79cd1727ed2d5cc673823dd4efdafac1
ToppCellCOVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type

FREM2 GDA CDH9 SORCS1

1.18e-0417863423a12d3d971b857d5be8e907334d1f6b49eeeb32
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PTK2B CDH9 SNTB2 SORCS1

1.20e-041796349ba8693fba2175bca9ff9735cc04e657abeb9084
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PTK2B GDA MYO1D DGKG

1.20e-04179634747a32460b257fffca30527b56a74720eb9c12e4
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

MYO1D CDH9 SNTB2 SORCS1

1.20e-04179634065a50952e8703fa07767beb6b73a090bf378ca6
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GDA SYT6 DGKG CDH9

1.23e-04180634e8841ef1239f9ee73ac4f4e11faca0742694f368
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

MYO1D DGKG CDH9 SNTB2

1.25e-041816349de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PTK2B MYO1D SNTB2 SORCS1

1.28e-04182634cc6f9d606a4f8717dc44928ceec2a257636043fd
ToppCellCOVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type

GDA MACC1 ABCA13 CDH9

1.31e-041836346878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MACC1 LIPC ABCA13 WDFY3

1.31e-0418363492fbd83a9d13ee91065cbd479fb298f1fd564568
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FREM2 ABCA13 TEX11 SORCS1

1.34e-04184634ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FREM2 ABCA13 TEX11 SORCS1

1.34e-041846342cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FREM2 ABCA13 TEX11 SORCS1

1.34e-041846342b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PTK2B MYO1D DGKG SNTB2

1.34e-041846349a185e6ea86bbfbb48bfe88650a8c05ceba78d7f
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MACC1 ABCA3 MYO1D MICAL2

1.34e-04184634ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCellPCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

FREM2 MACC1 GRB14 DGKG

1.34e-04184634fa4915b0498f3069fd5ef497286445528f75187e
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PTK2B GDA MYO1D MICAL2

1.39e-0418663484ba666237c18189d7e7556bd92dd953af733c00
ToppCellPCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

FREM2 MACC1 MICAL2 GRB14

1.39e-04186634bb0bfe9a015151be08a6ffc5d82896d0556d76de
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

MACC1 ABCA3 ABCA13 MICAL2

1.39e-04186634acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FREM2 MACC1 ABCA13 WDFY3

1.39e-041866345c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MACC1 ABCA3 MYO1D MICAL2

1.45e-041886344bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

RLF HUWE1 BIRC6 EPG5

1.45e-04188634ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MACC1 LIPC MYO1D ABCA13

1.45e-0418863463a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PTK2B GDA MICAL2 SORCS1

1.51e-04190634d594da827e3c16644952b9589cc12b947ce36279
ToppCellPCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

FREM2 MACC1 GRB14 DGKG

1.51e-04190634625c08a0e5227efc46daa512fd579c3938ff76c7
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PTK2B GDA MACC1 CDH9

1.51e-04190634989d4eefd22d66ecb857836f8fdbcf41e3047f84
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PTK2B GDA MICAL2 SORCS1

1.51e-0419063449e09cdb843b3d889a06a811aa5affae68b25a75
ToppCelldroplet-Lung-immune-endo-depleted-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MACC1 ABCA3 GRB14 TEX11

1.51e-04190634aaf5f1c1ff7b1454f4e5dacfeb48e1c3627e3372
ToppCelldroplet-Lung-immune-endo-depleted-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MACC1 ABCA3 GRB14 TEX11

1.51e-04190634a20123d5c6cb8c2f0dfd99bbfdb571a73c36234d
ToppCellControl-Stromal-SMC|Stromal / Disease state, Lineage and Cell class

MYO1D MICAL2 DGKG CARNS1

1.54e-041916342da83c493e60ad0278848957645277d76737a188
ToppCellChildren_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor

FREM2 ABCA3 MICAL2 SMYD3

1.54e-04191634e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCellfacs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MACC1 ABCA3 GRB14 TEX11

1.54e-04191634c06bbad24e4897b2c3b5015e4de02411ebf75367
ToppCellfacs-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MACC1 ABCA3 GRB14 TEX11

1.54e-041916345f43f98cfe7a08d61ed55f34808fabfe47f1ac2e
ToppCelldroplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MACC1 ABCA3 GRB14 TEX11

1.57e-0419263413e4b17d7a592604140777aca235f795df6b3f91
ToppCellPCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

FREM2 MACC1 GRB14 DGKG

1.57e-04192634b7c01e12b3e9be960a741b08835f1dfff65d0d47
ToppCelldroplet-Lung-3m-Epithelial-alveolar_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MACC1 ABCA3 GRB14 TEX11

1.57e-04192634f51b3fd962263920a6cae783ca7af13f5eb7aaa3
ToppCellEpithelial|World / Lineage, Cell type, age group and donor

FREM2 ABCA3 MYO1D MICAL2

1.57e-04192634499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCelldroplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MACC1 ABCA3 GRB14 TEX11

1.57e-041926346244541688f85917018a057aa0b3e5972934dfbc
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PTK2B GDA MICAL2 SORCS1

1.57e-041926345c7e8b80b44d9ce55c797cdf8267ac5382e26cac
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9

WDFY3 HUWE1 POMK BIRC6

1.60e-04193634abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCellFetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

FREM2 MACC1 ABCA3 MYO1D

1.60e-04193634a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

FREM2 USP13 ABCA3 MICAL2

1.64e-0419463497534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FREM2 MACC1 ABCA13 WDFY3

1.64e-041946348ddcaaf24cee6e30d5be52c0cbf778cfba309c53
ToppCellPCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

FREM2 MACC1 MICAL2 GRB14

1.64e-04194634c011cd59bb4ca4134331cba0f5d73bdbd7011d64
ToppCellnucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

FREM2 ABCA3 MICAL2 SMYD3

1.64e-0419463453f3e49e91b1096f3226010e2de767efb490dfe4
ToppCellPCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

FREM2 MACC1 MICAL2 GRB14

1.64e-04194634c47fc3f716ab091a39c20d7639ac783029589ee5
ToppCellnucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ABCA3 MYO1D MICAL2 SMYD3

1.67e-041956349406866f99555198a9be311fbd65751b70f35446
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FREM2 USP13 ABCA3 GRB14

1.70e-041966347e5addaa844e66f8160e05858c341866a80aed23
ToppCellPCW_10-12-Epithelial-Epithelial_alveolar-distal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

FREM2 MACC1 MICAL2 GRB14

1.70e-041966340a34a0009f479384f1994c6f977f942699a132c8
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37|World / Primary Cells by Cluster

GDA SYT6 CDH9 SORCS1

1.74e-0419763400d756bc0231e1b3b88430214338c1059cb11106
ToppCellPCW_13-14-Epithelial-Epithelial_alveolar-distal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

FREM2 MACC1 MICAL2 GRB14

1.74e-041976346852a8ec1397811bbdd1fc625c52ed4fa75a931e
ToppCellTracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations

MYO1D WDFY3 BIRC6 SMYD3

1.80e-0419963494b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCellControl-Control-Myeloid-Neutrophil|Control / Disease, condition lineage and cell class

ABCA13 PLXNC1 EXTL3 NOTCH1

1.84e-0420063495c41f147a1594d49e73cb56d86d301c3115ce20
ToppCellNeuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic

PTK2B MYO1D MICAL2 SORCS1

1.84e-042006344409065bc7aa995354c71e0f9d6f3726cf393d6b
ToppCelldroplet-Spleen-nan-21m-Hematologic-erythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GDA POMK TRIM10

2.73e-0489633e7d9498a1a3aa974fdd68b394c3eaff8e35c9727
DrugD-Au

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

8.65e-0877656CID000277822
DrugAa1

KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

1.36e-0783656CID009549188
DrugAC1L1AQK

EXTL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL2

1.15e-06119656CID000001105
DrugUCF 101

PPP2CA PPP2CB IDH3A

6.22e-0613653ctd:C501517
DrugKanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; PC3; HT_HG-U133A

ABCA3 GLP1R ABCD4 GON4L WDFY3 CPT1A

2.29e-052006564625_DN
Diseaseadenocarcinoma (implicated_via_orthology)

NOTCH1 NOTCH2

9.36e-057632DOID:299 (implicated_via_orthology)
Diseasecentral nervous system cancer (implicated_via_orthology)

NOTCH1 NOTCH2

9.36e-057632DOID:3620 (implicated_via_orthology)
DiseaseDiabetes Mellitus, Non-Insulin-Dependent

LIPC GLP1R GRB14 CPT1A NOTCH2

1.11e-04221635C0011860
DiseaseMalignant neoplasm of skin

PTK2B NOTCH1 NOTCH2

2.77e-0459633C0007114
DiseaseSkin Neoplasms

PTK2B NOTCH1 NOTCH2

2.77e-0459633C0037286
Diseasekiller cell immunoglobulin-like receptor 2DL4 measurement

KIR2DS4 KIR3DL2

2.92e-0412632EFO_0008197
DiseaseNeoplasm of uncertain or unknown behavior of bladder

NOTCH1 NOTCH2

4.63e-0415632C0496930
Diseaselevel of Phosphatidylcholine (16:0_16:0) in blood serum

LIPC SNX13

4.63e-0415632OBA_2045067
DiseaseBenign neoplasm of bladder

NOTCH1 NOTCH2

4.63e-0415632C0154017
DiseaseCarcinoma in situ of bladder

NOTCH1 NOTCH2

4.63e-0415632C0154091
DiseaseCarcinoma of bladder

NOTCH1 NOTCH2

6.71e-0418632C0699885
Diseasemyeloid white cell count

PTK2B LIPC MICAL2 ZNF516 DGKG PKN2 NOTCH2 SNX13

8.29e-04937638EFO_0007988
Diseasefree cholesterol:total lipids ratio, intermediate density lipoprotein measurement

LIPC CPT1A SNX13

8.37e-0486633EFO_0008595, EFO_0020945
Diseasedocosahexaenoic acid to total fatty acids percentage

LIPC CPT1A

9.18e-0421632EFO_0022262
DiseaseCerebral Astrocytoma

NOTCH1 NOTCH2

1.30e-0325632C0750935
DiseaseIntracranial Astrocytoma

NOTCH1 NOTCH2

1.30e-0325632C0750936
DiseasePilocytic Astrocytoma

NOTCH1 NOTCH2

1.30e-0325632C0334583
DiseaseAstrocytoma

NOTCH1 NOTCH2

1.30e-0325632C0004114
DiseaseJuvenile Pilocytic Astrocytoma

NOTCH1 NOTCH2

1.30e-0325632C0280783
DiseaseDiffuse Astrocytoma

NOTCH1 NOTCH2

1.30e-0325632C0280785
DiseaseGrade I Astrocytoma

NOTCH1 NOTCH2

1.30e-0325632C1704230
DiseaseSubependymal Giant Cell Astrocytoma

NOTCH1 NOTCH2

1.30e-0325632C0205768
DiseaseMixed oligoastrocytoma

NOTCH1 NOTCH2

1.30e-0325632C0547065
DiseaseChildhood Cerebral Astrocytoma

NOTCH1 NOTCH2

1.30e-0325632C0338070
Diseasebrain cancer (implicated_via_orthology)

NOTCH1 NOTCH2

1.41e-0326632DOID:1319 (implicated_via_orthology)
DiseaseGemistocytic astrocytoma

NOTCH1 NOTCH2

1.41e-0326632C0334581
DiseaseProtoplasmic astrocytoma

NOTCH1 NOTCH2

1.41e-0326632C0334580
DiseaseFibrillary Astrocytoma

NOTCH1 NOTCH2

1.41e-0326632C0334582
Diseaseenergy expenditure

CPT1A SMYD3

1.52e-0327632EFO_0005109
DiseaseAnaplastic astrocytoma

NOTCH1 NOTCH2

1.52e-0327632C0334579
Diseasecolorectal cancer (implicated_via_orthology)

NOTCH1 NOTCH2

1.88e-0330632DOID:9256 (implicated_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
EMKRRLTEVADFHHA

EPG5

1351

Q9HCE0
ERMHSGARRFVTLDF

BIRC6

1781

Q9NR09
HDFDHFHSLAIRGDM

BCDIN3D

216

Q7Z5W3
DSHRFGRHLKEAMTD

CPT1A

746

P50416
QTFIHFDMTEHRRDE

CARNS1

436

A5YM72
AFDVRAFTRDGHMAD

ABCA3

1166

Q99758
MEHHFRLSRFQTAAD

ABCA13

91

Q86UQ4
VDRDVRMFFHFSEIL

CSDE1

366

O75534
AAFYRAGHVEHMRTD

ABCD4

236

O14678
FHGVLRTIDMSFLHF

AADACL3

376

Q5VUY0
SDVMFEHFFLHREGI

KIR3DL2

146

P43630
HSEMTDFILAGFRVR

OR9K2

31

Q8NGE7
DHFANRDITDHMDRL

NOTCH2

2031

Q04721
SDVMFEHFLLHREGK

KIR2DS4

51

P43632
LDHFANRDITDHMDR

NOTCH1

2081

P46531
IFAFVMDEHARGTLR

GLP1R

366

P43220
TFDGVREMREAFTVH

FREM2

2326

Q5SZK8
IVPHMLRFTFRGHED

FER1L4

1026

A9Z1Z3
GGFTHIFTEDMHNRD

PLXNC1

1031

O60486
FVDAIHTFTREHMGL

LIPC

216

P11150
SDVMFEHFLLHREGT

KIR2DS3

51

Q14952
GDVHGQFHDLMELFR

PPP2CB

56

P62714
GDVHGQFHDLMELFR

PPP2CA

56

P67775
DMAVHVRRDHVFEDS

HUWE1

4016

Q7Z6Z7
SDVMFEHFLLHREGT

KIR2DS5

51

Q14953
GVDASIAHRFHVMRE

DGKG

586

P49619
RAVEFFGDEHMDEHL

CRNKL1

401

Q9BZJ0
RHMGLFDHAARIEAA

IDH3A

316

P50213
DAHLRHDEIMFGFRV

EXTL3

746

O43909
AEVSHRFRELMQLFH

GON4L

2191

Q3T8J9
LFSLVEHREMHLFDF

MACC1

471

Q6ZN28
RELSHHEFFMPGLVD

GDA

66

Q9Y2T3
DGEMFHTLDDGHTRF

GRB14

496

Q14449
HNVFKRHSMREEDFI

PTK2B

771

Q14289
HDVSFDFHGRRMATC

SEH1L

16

Q96EE3
VDRHTDMDRIFGIHS

CDH9

421

Q9ULB4
EHFLLHREGMFNDTL

KIR2DL1

56

P43626
LHAFIAEVFAMVRAH

C2CD5

916

Q86YS7
GRRFRQACDMVHHFT

CYP4F22

261

Q6NT55
VMERLSAEGHFFHRE

MICAL2

1011

O94851
REMHIETERFGDFHG

NXPE1

481

Q8N323
EHFLLHREGMFNDTL

KIR2DS1

56

Q14954
EMLFEDRTRAHADHI

RSBN1L

561

Q6PCB5
VFDFDRFSRHDMIGE

SYT6

316

Q5T7P8
FHDFHMRITEQFESL

SNX13

616

Q9Y5W8
FLLGHIEGSDMVRFH

POMK

291

Q9H5K3
IEGSDMVRFHLFDIH

POMK

296

Q9H5K3
ELRMEELRHHFRIEF

PKN2

216

Q16513
AFDIMRVTHGREHSL

SMYD3

396

Q9H7B4
RSDDGSFHIRDSHML

UHRF1BP1L

1351

A0JNW5
HMRAHSVVFESDGPR

ZNF516

1116

Q92618
RASFQRHMLTHAEDG

ZNF136

516

P52737
GHFDLADRMFHSVRE

WDFY3

2816

Q8IZQ1
RHFMSAFHLREHEQV

RLF

721

Q13129
EGTRFMGRHSEFAAH

SLC35B2

326

Q8TB61
LHGDFRRHFSMGNEV

VPS16

111

Q9H269
MDHERESVGFHFLTI

TEX11

346

Q8IYF3
DLHRQFPFHEMFAAR

TBC1D10B

406

Q4KMP7
DRSGNLRIHELHFMD

WDR62

511

O43379
MVAFFHEEEQRHLER

TRIM51G

186

A0A3B3IT33
CREAGEHATHTMRFL

TRIM10

121

Q9UDY6
EETLIMTVFGHFSHR

SORCS1

641

Q8WY21
GIEMHLFRVETHRDL

SNTB2

411

Q13425
RDLHRQFPFHEMFVS

TBC1D10A

156

Q9BXI6
ISAFHEDSRFIDHLM

TTC4

291

O95801
MNTFLAFGREHVERH

USP13

66

Q92995
HEVARRFHGVKTMRD

MYO1D

741

O94832
DGSHLGRVATHFRDM

EXD3

841

Q8N9H8